CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1

被引:137
作者
Li, Dongbao [1 ]
Wang, Yuhong [2 ]
Dong, Chao [1 ]
Chen, Tao [1 ]
Dong, Anqi [1 ]
Ren, Jiayu [1 ]
Li, Weikang [1 ]
Shu, Gege [1 ]
Yang, Jiaoyang [1 ]
Shen, Wenhao [3 ,4 ]
Qin, Lei [1 ]
Hu, Lin [3 ,4 ]
Zhou, Jin [1 ]
机构
[1] Soochow Univ, Dept Gen Surg, Affiliated Hosp 1, Suzhou 215006, Jiangsu, Peoples R China
[2] Soochow Univ, Dept Pathol, Affiliated Hosp 1, Suzhou 215006, Jiangsu, Peoples R China
[3] Soochow Univ, Collaborat Innovat Ctr Radiat Med Jiangsu Higher, State Key Lab Radiat Med & Protect, Sch Radiat Med & Protect, Suzhou 215123, Jiangsu, Peoples R China
[4] Soochow Univ, Collaborat Innovat Ctr Radiat Med Jiangsu Higher, Sch Radiol & Interdisciplinary Sci RADX, Suzhou 215123, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
CYSTATIN SN; CELL-PROLIFERATION; DEUBIQUITINASE; MIGRATION; INVASION;
D O I
10.1038/s41388-022-02537-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metastasis is an important factor contributing to poor prognosis in patients with gastric cancer; yet, the molecular mechanism leading to this cell behavior is still not well understood. In this study, we explored the role of cysteine protease inhibitor SN (Cystatin SN, CST1) in promoting gastric cancer metastasis. We hypothesized that CST1 could regulate gastric cancer progression by regulating GPX4 and ferroptosis. Whole transcriptome sequencing suggested that the expression of CST1 was significantly increased in metastatic cancer, and high CST1 expression was correlated with a worse prognosis. Our data further confirmed that the overexpression of CST1 may significantly promote the migration and invasion of gastric cancer cells in vitro and enhance liver, lung, and peritoneal metastasis of gastric cancer in nude mice. Meanwhile, high expression of CST1 promoted the epithelial-mesenchymal transition (EMT) of gastric cancer cells. Mechanistically, a co-immunoprecipitation experiment combined with mass spectrometry analysis confirmed that CST1 could interact with GPX4, a key protein regulating ferroptosis. CST1 relieves GPX4 ubiquitination modification by recruiting OTUB1, improving GPX4 protein stability and reducing intracellular reactive oxygen species (ROS), thereby inhibiting ferroptosis and, in turn, promoting gastric cancer metastasis. Moreover, clinical data suggested that CST1 is significantly increased in peripheral blood and ascites of gastric cancer patients with metastasis; multivariate Cox regression model analysis showed that CST1 was an independent risk factor for the prognosis of gastric cancer patients. Overall, our results elucidated a critical pathway through which high CST1 expression protects gastric cancer cells from undergoing ferroptosis, thus promoting its progression and metastasis. CST1 may be used as a new oncological marker and potential therapeutic target for gastric cancer metastasis.
引用
收藏
页码:83 / 98
页数:16
相关论文
共 43 条
  • [1] Cystatins
    Abrahamson, M
    Alvarez-Fernandez, M
    Nathanson, CM
    [J]. PROTEASES AND THE REGULATION OF BIOLOGICAL PROCESSES, 2003, 70 : 179 - 199
  • [2] EMT, MET, Plasticity, and Tumor Metastasis
    Bakir, Basil
    Chiarella, Anna M.
    Pitarresi, Jason R.
    Rustgi, Anil K.
    [J]. TRENDS IN CELL BIOLOGY, 2020, 30 (10) : 764 - 776
  • [3] ROS and oncogenesis with special reference to EMT and stemness
    Chatterjee, Ritam
    Chatterjee, Jyotirmoy
    [J]. EUROPEAN JOURNAL OF CELL BIOLOGY, 2020, 99 (2-3)
  • [4] CST1 Promoted Gastric Cancer Migration and Invasion Through Activating Wnt Pathway
    Chen, Si
    Liu, Yingling
    Zhang, Kaiguang
    Chen, Lele
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 1901 - 1907
  • [5] Broadening horizons: the role of ferroptosis in cancer
    Chen, Xin
    Kang, Rui
    Kroemer, Guido
    Tang, Daolin
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (05) : 280 - 296
  • [6] Cellular degradation systems in ferroptosis
    Chen, Xin
    Yu, Chunhua
    Kang, Rui
    Kroemer, Guido
    Tang, Daolin
    [J]. CELL DEATH AND DIFFERENTIATION, 2021, 28 (04) : 1135 - 1148
  • [7] Upregulation of the cysteine protease inhibitor, cystatin SN, contributes to cell proliferation and cathepsin inhibition in gastric cancer
    Choi, Eun Hwa
    Kim, Jong-Tae
    Kim, Joo Heon
    Kim, Soo-Young
    Song, Eun Young
    Kim, Jae Wha
    Kim, Seon Young
    Yeom, Young Il
    Kim, Ik-Hwan
    Lee, Hee Gu
    [J]. CLINICA CHIMICA ACTA, 2009, 406 (1-2) : 45 - 51
  • [8] Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis
    Cui, Yifeng
    Sun, Dan
    Song, Ruipeng
    Zhang, Shugeng
    Liu, Xirui
    Wang, Yan
    Meng, Fanzheng
    Lan, Yaliang
    Han, Jihua
    Pan, Shangha
    Liang, Shuhang
    Zhang, Bo
    Guo, Hongrui
    Liu, Yufeng
    Lu, Zhaoyang
    Liu, Lianxin
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (12) : 22623 - 22634
  • [9] Deubiquitinase inhibition as a cancer therapeutic strategy
    D'Arcy, Padraig
    Wang, Xin
    Linder, Stig
    [J]. PHARMACOLOGY & THERAPEUTICS, 2015, 147 : 32 - 54
  • [10] Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis
    Dai, Da-nian
    Li, Yan
    Chen, Bo
    Du, Yong
    Li, Shi-bing
    Lu, Shi-xun
    Zhao, Zhi-ping
    Zhou, Ai-jun
    Xue, Ning
    Xia, Tian-liang
    Zeng, Mu-sheng
    Zhong, Qian
    Wei, Wei-dong
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2017, 95 (08): : 873 - 886